- NCIt
- C9479
Loading cancer entity…
Loading cancer entity…
Clinical trials
78 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (3)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03030404 | Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer | completed | — | 733 | National Cancer Institute (NCI)NIH | 1 | Sep 28, 2026 | clinicaltrials |
| NCT04471961 | Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child Neoplasia(ALADIN) | completed | N/A | 100 | University Hospital, MontpellierOTHER | 1 | Jun 22, 2026 |
| clinicaltrials |
| NCT04214210 | The DIALOGUE Study: Swiss-Korean Billateral Collaboration(DIALOGUE) | completed | N/A | 128 | University of BaselOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT02595905 | Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases | completed | Phase 2 | 344 | National Cancer Institute (NCI)NIH | 2 | Apr 8, 2026 | clinicaltrials |
| NCT04965597 | Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904) | completed | Phase 2 | 40 | Fred Hutchinson Cancer CenterOTHER | 1 | Mar 9, 2026 | clinicaltrials |
| NCT07416812 | Targeted Prostate Cancer Screening in Men With BRCA1/2 Mutations(IMPACT) | completed | N/A | 25 | Institute of Oncology LjubljanaOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT06284330 | CHARGE Study: CHoice ARchitecture Genetic tEsting(CHARGE) | completed | N/A | 108 | University of Texas Southwestern Medical CenterOTHER | 1 | Sep 5, 2025 | clinicaltrials |
| NCT05687474 | Baby Detect : Genomic Newborn Screening(BabyDetect) | completed | — | 6,824 | Centre Hospitalier Universitaire de LiegeOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT06378749 | Previvors Recharge: A Resilience Program for Cancer Previvors(PreCharge) | completed | N/A | 138 | Pro-Change Behavior SystemsOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT03934606 | Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model | completed | — | 1,488 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT01130519 | A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer | completed | Phase 2 | 83 | National Cancer Institute (NCI)NIH | 1 | Feb 21, 2025 | clinicaltrials |
| NCT04253106 | Liquid Biopsies for the Personalized Management of Patients with Hereditary Diffuse Gastric Cancer(LISA-HDGC) | completed | N/A | 16 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 23, 2024 | clinicaltrials |
| NCT04242667 | Penn Biobank Return of Research Results Program | completed | N/A | 260 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT00390325 | Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer | completed | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Feb 6, 2024 | clinicaltrials |
| NCT02560896 | Understanding Genetic Incidental Findings in Your Family (UNIFY Study)(UNIFY) | completed | — | 12 | Mayo ClinicOTHER | 1 | Jun 6, 2023 | clinicaltrials |
| NCT05805982 | Educational Video Versus In-person Genetic Counseling for Hereditary Cancer | completed | N/A | 251 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranOTHER | 1 | Apr 10, 2023 | clinicaltrials |
| NCT01013129 | Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer | completed | — | 748 | Portland VA Medical CenterFED | 1 | Nov 11, 2021 | clinicaltrials |
| NCT03959267 | Testing a Culturally Adapted Telephone Genetic Counseling Intervention | completed | N/A | 37 | Georgetown UniversityOTHER | 1 | Sep 1, 2021 | clinicaltrials |
| NCT03982446 | Germline Mutations in Pancreatic Adenocarcinoma(PaMPA) | completed | — | 549 | Hellenic Cooperative Oncology GroupOTHER | 1 | Feb 12, 2021 | clinicaltrials |
| NCT02381015 | Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a | completed | N/A | 700 | Endeavor HealthOTHER | 0 | Nov 22, 2019 | clinicaltrials |
| NCT03950908 | Biopsy Technique for Endoscopic Surveillance of Hereditary Diffuse Gastric Cancer | completed | N/A | 48 | University of CambridgeOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT03421327 | Genetic Risk: Whether, When, and How to Tell Adolescents | completed | — | 85 | Johns Hopkins UniversityOTHER | 1 | Feb 7, 2019 | clinicaltrials |
| NCT02557776 | Written Genetic Counseling and Mutation Analysis of BRCA1 and BRCA2 to Patients With Breast Cancer(BRCAsearch) | completed | N/A | 542 | Lund UniversityOTHER | 1 | Feb 6, 2019 | clinicaltrials |
| NCT03067389 | Combined Breast Cancer Risk Study | completed | — | 553 | Myriad Genetic Laboratories, Inc.INDUSTRY | 1 | Jan 15, 2019 | clinicaltrials |
| NCT00633607 | Hereditary Colorectal and Associated Tumor Registry Study | completed | — | 114 | University of PittsburghOTHER | 1 | Feb 19, 2018 | clinicaltrials |
| NCT01853306 | A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors | completed | Phase 1 | 71 | AbbVieINDUSTRY | 0 | Nov 21, 2017 | clinicaltrials |
| NCT03081455 | Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes | completed | — | 145 | Myriad Genetic Laboratories, Inc.INDUSTRY | 1 | Aug 8, 2017 | clinicaltrials |
| NCT00971620 | Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin | completed | Phase 2 | 18 | National Cancer Institute (NCI)NIH | 1 | Apr 7, 2017 | clinicaltrials |
| NCT01353300 | Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer | completed | — | 31 | Children's Oncology GroupNETWORK | 0 | Jul 11, 2016 | clinicaltrials |
Data updated 2 days agoSource updated Sep 28, 2026source: clinicaltrials